CV Lattes
Secretaria da Saúde (São Paulo - Estado). Instituto Butantan (Institutional affiliation from the last research proposal) Birthplace: Brazil
PhD from the Interunits Biotecnology Program at USP with a project of expression and purification of pneumococci proteins for development of a vaccine based on lipossomes and formulated as dry microcarriers for pulmonary immunization against pneumococcal pneumonia. Gradueted in Pharmacy at Mackenzie Presbyterian University (2015) and Master degree in Biotecnology at São Paulo University (2018) with a project based on pulmonary immunization of mice with polymeric nanoparticles adsorbed with a penumococcal protein. Has knowledge in molecular baiology techniques, protein purification and immulonogic techniques such as PCR, cloning and gene expression in E. coli, SDS-PAGE and western blot, flow cytometry, ELISA, Luminex. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Streptococcus pneumoniae, or pneumococcus, is a component of the human microbiota, but in some cases it can cause diseases such as Sinusitis, Otitis Media, Pneumonia, Sepsis and Meningitis. Vaccination is the most effective strategy to control pneumococcal infections. The first generation pneumococcal vaccines are composed by free capsular polysaccharides (PS), inducing temporary protecti…
Streptococcus pneumoniae is an important human pathogen, causing many severe diseases such as meningitis, pneumonia, bacteremia and sepsis. The vaccines currently available are based on the induction of antibodies against the capsular polysaccharide, but they present some disadvantages, such as high cost and coverage restricted to serotypes included in the formulations. The use of the 7-v…
Streptococcus pneumoniae, or pneumococcus, is a component of human microbiota, but in some cases it can cause serious diseases. Vaccines are the most important way to control pneumococcal infections and there are currently two licensed vaccines based on capsular polysaccharides (PS). The pneumococcal conjugate vaccines (PCVs) led to an impressive decrease in the cases of invasive pneumoco…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |